Mounjaro® (Tirzepatide Injection) – 2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg

Mounjaro® (Tirzepatide Injection) is a prescription injectable medication used for type 2 diabetes management and medical weight management. It works through a dual GIP and GLP-1 receptor mechanism, helping regulate blood sugar levels and support appetite control under medical supervision.

Mounjaro is administered as a once-weekly injection and is available in multiple dosage strengths to support gradual dose escalation as advised by healthcare professionals.

Available Strengths

• Mounjaro 2.5 mg Injection

• Mounjaro 5 mg Injection

• Mounjaro 7.5 mg Injection

• Mounjaro 10 mg Injection

• Mounjaro 12.5 mg Injection

• Mounjaro 15 mg Injection

Key Highlights

• Dual-action GLP-1/GIP therapy

• Once-weekly dosing convenience

• Used in obesity and metabolic health programs

• Prescription-only medication

• Suitable for retail, hospital, and export enquiries

For International Buyers

Medicina Overseas supplies Mounjaro (Tirzepatide Injection) for global B2B export markets, including pharmacies, hospitals, distributors, and healthcare providers. Documentation support and bulk enquiries available on request.

⚠️ This medicine is supplied strictly against prescription and subject to country-specific regulations.